+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Coronavirus Vaccine Market By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV, SARS-CoV-2, Others), By Vaccine Type, By Product Type, By Route of Administration, By Patient Type, By End User, By Region, Forecast & Opportunities, 2025

  • ID: 5031334
  • Report
  • May 2020
  • Region: Global
  • 120 pages
  • TechSci Research
UP TO OFF
until Jul 31st 2020
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Coronavirus Vaccine Market is Driven by the Increasing Prevalence of This Disease Across Different Parts of the Globe.

FEATURED COMPANIES

  • Airway Therapeutics
  • CanSino Biological Inc
  • GlaxoSmithKline (GSK)
  • Medicago
  • Novavax, Inc.
  • Sanofi
  • MORE
Coronaviruses are a group of viruses belonging to the coronaviridae family that can affect both mammals and birds. The common symptoms include mild illness such as common cold, respiratory tract infections, while the lethal symptoms comprise of SARS, MERS, SARS-COV-2, among others.

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from the saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. The first case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 13th April 2020, coronavirus has affected around 210 countries & territories with the total number of coronavirus cases reaching 1,854,043 out of which 427,879 have recovered and around 114,291 people have succumbed to the disease.

The Global Coronavirus Vaccine Market is expected to grow at a robust rate during the forecast period. The Global Coronavirus Vaccine Market is driven by the increasing prevalence of this disease across different parts of the globe. This has increased the need to protect the world from the virus, thereby expected to positively impact the market growth. Furthermore, increasing R&D activities by various pharmaceutical & biotechnology players for the development of potential vaccines is anticipated to foster the market growth. According to WHO, there are 70 coronavirus vaccines under development by different companies and organizations. Out of these, three vaccines are already being tested in human trials. The vaccine developed by the Hong Kong based biopharmaceutical firm CanSino Biologics Inc. and the Beijing Institute of Biotechnology is leading the race and is currently in the second phase of clinical trials. On the other hand, other vaccines developed by the US-based companies Moderna Inc. and Inovio Pharmaceuticals Inc., have also started their human trials.

The Global Coronavirus Vaccine Market is segmented based on infection type, vaccine type, product type, route of administration, patient type, end-user, company and region. Based on infection type, the market can be categorized into HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV, SARS-CoV-2 and others. The SARS-CoV-2 segment is expected to dominate the market since this infection or virus is the cause of the pandemic COVID-19 disease.

Regionally, the Global Coronavirus Vaccine Market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, Asia-Pacific is expected to witness significant growth during the forecast period in the overall coronavirus vaccine market since China was the epicenter for the novel coronavirus disease and various Chinese companies & research institutes have already started working on various treatment options and vaccines to fight the disease. Additionally, other countries in the region such as India, Singapore, South Korea are also aggressively involved in developing vaccines and other treatments to curb the disease.

Major players operating in the Global Coronavirus Vaccine Market include Inovio Pharmaceuticals, Inc., Moderna, Inc., Novavax, Inc., Johnson & Johnson, Pfizer, Sanofi, Protein Potential, LLC, AlphaVax, Inc., Synairgen PLC, NanoViricides, Inc., GeneCure, LLC, GlaxoSmithKline (GSK), Zydus Cadila, Serum Institute, Bharat Biotech, CanSino Biological Inc, FluGen, I-Mab Biopharma, Medicago, Airway Therapeutics and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Year: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025
Objective of the Study:
  • To analyze and estimate the market size of the Global Coronavirus Vaccine Market from 2015 to 2018.
  • To estimate and forecast the market size of the Global Coronavirus Vaccine Market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast the Global Coronavirus Vaccine Market based on infection type, vaccine type, product type, route of administration, patient type, end-user, company and regional distribution.
  • To identify dominant region or segment in the Global Coronavirus Vaccine Market.
  • To identify drivers and challenges for the Global Coronavirus Vaccine Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Coronavirus Vaccine Market.
  • To conduct pricing analysis for the Global Coronavirus Vaccine Market.
  • To identify and analyze the profile of leading players operating in the Global Coronavirus Vaccine Market.
  • To identify key sustainable strategies adopted by market players in the Global Coronavirus Vaccine Market.
The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of manufacturers across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the manufacturers which could not be identified due to the limitations of secondary research. The author analyzed the manufacturers, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Coronavirus Vaccine Market by using a bottom-up approach, wherein the data for various end-user segments was recorded and forecast for the future years. The author sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Coronavirus vaccine manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to coronavirus vaccine
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Coronavirus Vaccine Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Coronavirus Vaccine Market, By Infection Type:
  • HCoV-229E
  • HCoV-OC43
  • SARS-CoV
  • New Haven CoV
  • HKU1-CoV
  • MERS-CoV
  • SARS-CoV-2
  • Others
Global Coronavirus Vaccine Market, By Vaccine Type:
  • Inactivated Coronavirus Vaccine
  • Live Attenuated Coronavirus Vaccine
  • S-Protein Based Coronavirus Vaccine
Global Coronavirus Vaccine Market, By Product Type:
  • Monovalent Vaccine
  • Multivariant Vaccine
Global Coronavirus Vaccine Market, By Route of Administration:
  • Oral
  • Intramuscular
  • Subcutaneous
Global Coronavirus Vaccine Market, By Patient Type:
  • Pediatric
  • Adult
Global Coronavirus Vaccine Market, By End-User:
  • Hospitals
  • Clinics
  • Research Institutes
  • Others
Global Coronavirus Vaccine Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Hong Kong
  • Thailand
  • Singapore
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Iran
  • South America
  • Brazil
  • Argentina
  • Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Coronavirus Vaccine Market.

Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. If you buy the ‘Multi-user’ License of this report before June 2020, you will get a free update in form of market data excel sheet within 3 to 6 months of your purchase on request.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Airway Therapeutics
  • CanSino Biological Inc
  • GlaxoSmithKline (GSK)
  • Medicago
  • Novavax, Inc.
  • Sanofi
  • MORE
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Coronavirus Vaccine Market

4. Executive Summary

5. Voice of Customer

6. Global Coronavirus Vaccine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV, SARS-CoV-2, Others)
6.2.2. By Vaccine Type (Inactivated Coronavirus Vaccine, Live Attenuated Coronavirus Vaccine, S-Protein Based Coronavirus Vaccine)
6.2.3. By Product Type (Monovalent Vaccine v/s Multivariant Vaccine)
6.2.4. By Route of Administration (Oral, Intramuscular, Subcutaneous)
6.2.5. By Patient Type (Pediatric v/s Adult)
6.2.6. By End User (Hospitals, Clinics, Research Institutes, Others)
6.2.7. By Company (2019)
6.2.8. By Region
6.3. Product Market Map

7. Asia-Pacific Coronavirus Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Infection Type
7.2.2. By Vaccine Type
7.2.3. By Product Type
7.2.4. By Route of Administration
7.2.5. By Patient Type
7.2.6. By End User
7.2.7. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Coronavirus Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Infection Type
7.3.1.2.2. By Vaccine Type
7.3.1.2.3. By Product Type
7.3.1.2.4. By Route of Administration
7.3.1.2.5. By Patient Type
7.3.1.2.6. By End User
7.3.2. India Coronavirus Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Infection Type
7.3.2.2.2. By Vaccine Type
7.3.2.2.3. By Product Type
7.3.2.2.4. By Route of Administration
7.3.2.2.5. By Patient Type
7.3.2.2.6. By End User
7.3.3. Australia Coronavirus Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Infection Type
7.3.3.2.2. By Vaccine Type
7.3.3.2.3. By Product Type
7.3.3.2.4. By Route of Administration
7.3.3.2.5. By Patient Type
7.3.3.2.6. By End User
7.3.4. Japan Coronavirus Vaccine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Infection Type
7.3.4.2.2. By Vaccine Type
7.3.4.2.3. By Product Type
7.3.4.2.4. By Route of Administration
7.3.4.2.5. By Patient Type
7.3.4.2.6. By End User
7.3.5. South Korea Coronavirus Vaccine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Infection Type
7.3.5.2.2. By Vaccine Type
7.3.5.2.3. By Product Type
7.3.5.2.4. By Route of Administration
7.3.5.2.5. By Patient Type
7.3.5.2.6. By End User
7.3.6. Hong Kong Coronavirus Vaccine Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Infection Type
7.3.6.2.2. By Vaccine Type
7.3.6.2.3. By Product Type
7.3.6.2.4. By Route of Administration
7.3.6.2.5. By Patient Type
7.3.6.2.6. By End User
7.3.7. Thailand Coronavirus Vaccine Market Outlook
7.3.7.1. Market Size & Forecast
7.3.7.1.1. By Value
7.3.7.2. Market Share & Forecast
7.3.7.2.1. By Infection Type
7.3.7.2.2. By Vaccine Type
7.3.7.2.3. By Product Type
7.3.7.2.4. By Route of Administration
7.3.7.2.5. By Patient Type
7.3.7.2.6. By End User
7.3.8. Singapore Coronavirus Vaccine Market Outlook
7.3.8.1. Market Size & Forecast
7.3.8.1.1. By Value
7.3.8.2. Market Share & Forecast
7.3.8.2.1. By Infection Type
7.3.8.2.2. By Vaccine Type
7.3.8.2.3. By Product Type
7.3.8.2.4. By Route of Administration
7.3.8.2.5. By Patient Type
7.3.8.2.6. By End User

8. Europe Coronavirus Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Infection Type
8.2.2. By Vaccine Type
8.2.3. By Product Type
8.2.4. By Route of Administration
8.2.5. By Patient Type
8.2.6. By End User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. France Coronavirus Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Infection Type
8.3.1.2.2. By Vaccine Type
8.3.1.2.3. By Product Type
8.3.1.2.4. By Route of Administration
8.3.1.2.5. By Patient Type
8.3.1.2.6. By End User
8.3.2. Germany Coronavirus Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Infection Type
8.3.2.2.2. By Vaccine Type
8.3.2.2.3. By Product Type
8.3.2.2.4. By Route of Administration
8.3.2.2.5. By Patient Type
8.3.2.2.6. By End User
8.3.3. United Kingdom Coronavirus Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Infection Type
8.3.3.2.2. By Vaccine Type
8.3.3.2.3. By Product Type
8.3.3.2.4. By Route of Administration
8.3.3.2.5. By Patient Type
8.3.3.2.6. By End User
8.3.4. Italy Coronavirus Vaccine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Infection Type
8.3.4.2.2. By Vaccine Type
8.3.4.2.3. By Product Type
8.3.4.2.4. By Route of Administration
8.3.4.2.5. By Patient Type
8.3.4.2.6. By End User
8.3.5. Spain Coronavirus Vaccine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Infection Type
8.3.5.2.2. By Vaccine Type
8.3.5.2.3. By Product Type
8.3.5.2.4. By Route of Administration
8.3.5.2.5. By Patient Type
8.3.5.2.6. By End User

9. North America Coronavirus Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Infection Type
9.2.2. By Vaccine Type
9.2.3. By Product Type
9.2.4. By Route of Administration
9.2.5. By Patient Type
9.2.6. By End User
9.2.7. By Country
9.3. North America: Country Analysis
9.3.1. United States Coronavirus Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Infection Type
9.3.1.2.2. By Vaccine Type
9.3.1.2.3. By Product Type
9.3.1.2.4. By Route of Administration
9.3.1.2.5. By Patient Type
9.3.1.2.6. By End User
9.3.2. Mexico Coronavirus Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Infection Type
9.3.2.2.2. By Vaccine Type
9.3.2.2.3. By Product Type
9.3.2.2.4. By Route of Administration
9.3.2.2.5. By Patient Type
9.3.2.2.6. By End User
9.3.3. Canada Coronavirus Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Infection Type
9.3.3.2.2. By Vaccine Type
9.3.3.2.3. By Product Type
9.3.3.2.4. By Route of Administration
9.3.3.2.5. By Patient Type
9.3.3.2.6. By End User

10. South America Coronavirus Vaccine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Infection Type
10.2.2. By Vaccine Type
10.2.3. By Product Type
10.2.4. By Route of Administration
10.2.5. By Patient Type
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Coronavirus Vaccine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Infection Type
10.3.1.2.2. By Vaccine Type
10.3.1.2.3. By Product Type
10.3.1.2.4. By Route of Administration
10.3.1.2.5. By Patient Type
10.3.1.2.6. By End User
10.3.2. Argentina Coronavirus Vaccine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Infection Type
10.3.2.2.2. By Vaccine Type
10.3.2.2.3. By Product Type
10.3.2.2.4. By Route of Administration
10.3.2.2.5. By Patient Type
10.3.2.2.6. By End User
10.3.3. Colombia Coronavirus Vaccine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Infection Type
10.3.3.2.2. By Vaccine Type
10.3.3.2.3. By Product Type
10.3.3.2.4. By Route of Administration
10.3.3.2.5. By Patient Type
10.3.3.2.6. By End User

11. Middle East and Africa Coronavirus Vaccine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Infection Type
11.2.2. By Vaccine Type
11.2.3. By Product Type
11.2.4. By Route of Administration
11.2.5. By Patient Type
11.2.6. By End User
11.2.7. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Coronavirus Vaccine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Infection Type
11.3.1.2.2. By Vaccine Type
11.3.1.2.3. By Product Type
11.3.1.2.4. By Route of Administration
11.3.1.2.5. By Patient Type
11.3.1.2.6. By End User
11.3.2. Saudi Arabia Coronavirus Vaccine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Infection Type
11.3.2.2.2. By Vaccine Type
11.3.2.2.3. By Product Type
11.3.2.2.4. By Route of Administration
11.3.2.2.5. By Patient Type
11.3.2.2.6. By End User
11.3.3. UAE Coronavirus Vaccine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Infection Type
11.3.3.2.2. By Vaccine Type
11.3.3.2.3. By Product Type
11.3.3.2.4. By Route of Administration
11.3.3.2.5. By Patient Type
11.3.3.2.6. By End User
11.3.4. Kuwait Coronavirus Vaccine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Infection Type
11.3.4.2.2. By Vaccine Type
11.3.4.2.3. By Product Type
11.3.4.2.4. By Route of Administration
11.3.4.2.5. By Patient Type
11.3.4.2.6. By End User

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles
15.3. Company Details
15.4. Financials (As Reported)
15.5. Supply/ Value Chain Analysis
15.6. Timelines For Drug Development To Commercial Launch
15.6.1. Status of Approval of vaccines
15.7. SWOT Analysis
15.8. Key Market Focus and Geographical Presence
15.9. Planned Investments
15.10. Market Positioning
15.11. Leading Players Profiled
15.11.1. Inovio Pharmaceuticals, Inc.
15.11.2. Moderna, Inc.
15.11.3. Novavax, Inc.
15.11.4. Johnson & Johnson
15.11.5. Pfizer
15.11.6. Sanofi
15.11.7. Protein Potential, LLC
15.11.8. AlphaVax, Inc.
15.11.9. Synairgen PLC
15.11.10. NanoViricides, Inc.
15.11.11. GeneCure, LLC
15.11.12. GlaxoSmithKline (GSK)
15.11.13. Zydus Cadila
15.11.14. Serum Institute
15.11.15. Bharat Biotech
15.11.16. CanSino Biological Inc
15.11.17. FluGen
15.11.18. I-Mab Biopharma
15.11.19. Medicago
15.11.20. Airway Therapeutics

16. Strategic Recommendations

17. About the author & Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Inovio Pharmaceuticals, Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Johnson & Johnson
  • Pfizer
  • Sanofi
  • Protein Potential, LLC
  • AlphaVax, Inc.
  • Synairgen PLC
  • NanoViricides, Inc.
  • GeneCure, LLC
  • GlaxoSmithKline (GSK)
  • Zydus Cadila
  • Serum Institute
  • Bharat Biotech
  • CanSino Biological Inc
  • FluGen
  • I-Mab Biopharma
  • Medicago
  • Airway Therapeutics
Note: Product cover images may vary from those shown
Adroll
adroll